Key Findings:  Despite the lack of controlled studies there is evidence that cannabinoids are of therapeutic value in the treatment of tics in Tourette syndrome, the reduction of levodopa-induced dyskinesia in Parkinson''s disease and some forms of tremor and dystonia. It can be speculated that cannabinoid antagonists might be useful in the treatment of chorea in Huntington''s disease and hypokinetic parkinsonian syndromes.
Type of Study:  Meta-analysis
Study Result:  Positive
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable